GPCR missed EPS expectations by 283.93%
Aug 07, 2025, 10:33 AM
0.00%
What does GPCR do
Structure Therapeutics, a clinical stage biopharmaceutical company based in South San Francisco, focuses on developing oral therapeutics targeting GPCRs for chronic diseases. It went public on February 3, 2023, and employs 111 people.
Structure Therapeutics (GPCR) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Structure Therapeutics's actual EPS was -$1.08, missing the estimate of -$0.28 per share, resulting in a -283.93% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.